Litcius/Paper detail

Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide

Martin Reck, Tony Mok, Aaron S. Mansfield, Richard de Boer, György Losonczy, Shunichi Sugawara, Rafał Dziadziuszko, Maciej Krzakowski, Alexey Smolin, Maximilian J. Hochmair, Marina Chiara Garassino, Gilberto de Castro, Helge Bischoff, Sivuonthanh Lam, Andrés F. Cardona, Stefanie Morris, Stephen V. Liu

2022Journal of Thoracic Oncology29 citationsDOIOpen Access PDF

Topics & Concepts

AtezolizumabMedicinePlaceboMaintenance therapyHazard ratioInternal medicineOncologyCarboplatinPopulationChemotherapyCancerConfidence intervalImmunotherapyPembrolizumabPathologyCisplatinEnvironmental healthAlternative medicineLung Cancer Research StudiesIntraperitoneal and Appendiceal MalignanciesPARP inhibition in cancer therapy
Brief Report: Exploratory Analysis of Maintenance Therapy in Patients With Extensive-Stage SCLC Treated First Line With Atezolizumab Plus Carboplatin and Etoposide | Litcius